WHO ICTRP trial
Efficacy of IOP reduction and safety of Eybelis ophthalmic solution 0.002%
JPRN-UMIN000035240 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000035240 |
|---|---|
| Public title | Efficacy of IOP reduction and safety of Eybelis ophthalmic solution 0.002% |
| Scientific title | Efficacy of IOP reduction and safety of Eybelis ophthalmic solution 0.002% - Efficacy of IOP reduction and safety of Eybelis ophthalmic solution 0.002% |
| Primary sponsor | Inouye Eye Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | glaucoma or ocular hypertension |
| Interventions | Topical ophthtalmic therapy with Eberis ophthalmic solution 0.002% |
| Registration date | Dec 13, 2018 |
| Target size | 100 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: